Navigation Links
Study: Patient Harm More Common with Patient-Controlled Pain Medication
Date:12/1/2008

OAKBROOK, Ill., Dec. 1 /PRNewswire-USNewswire/ -- Intravenous patient-controlled analgesia (PCA) allows patients to control their own pain medication, but a new study published in the December 2008 issue of The Joint Commission Journal on Quality and Patient Safety shows that errors related to this practice are four times more likely to result in patient harm than errors that occur with other medications.

The study of more than 9,500 PCA errors over a five-year period in the United States showed that patient harm occurred in 6.5 percent of incidents, compared to 1.5 percent for general medication errors. The PCA errors examined also were more severe -- harming patients and requiring clinical interventions in response to the error -- than other types of medication errors. Most errors involved either the wrong dosage or the wrong drug caused by human factors, equipment or communication breakdowns. For example, one case involved a patient who received several 10 mg doses instead of 1 mg medication doses after surgery because of an incorrectly programmed dispensing pump. The PCA errors examined also were more severe -- harming patients and requiring clinical interventions in response to the error -- than other types of medication errors.

"The entire PCA process is highly complex," says the study's lead author Rodney W. Hicks, Ph.D., M.S.N., M.P.A., UMC Health System Endowed Chair for Patient Safety and Professor, Anita Thigpen Perry School of Nursing, Texas Tech University Health Sciences Center, Lubbock, Texas. "PCA orders must be written, reviewed and then accurately programmed into sophisticated delivery devices for patients to be pain free. Such complexity makes PCA an error prone process. Health care organizations should now plan to make the process safer."

Through this method, a patient can administer doses of pain medication with the push of a button. A computerized pump that con
'/>"/>

SOURCE The Joint Commission
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study: Childhood constipation just as serious as asthma
2. Study: Want to be happier? Be more grateful
3. Study: Smoking Ban Would Help Reduce Heart Attack Admissions
4. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
5. University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria
6. Geisinger study: Increasing health care value improves health care quality
7. UNC study: Parenting can override effect of genes in how babies respond to stress
8. Study: Delaying evolution of drug resistance in malaria parasite possible
9. U. of Chicago study: More than 10 percent of older Americans suffer mistreatment
10. UNC study: chilling hardship rates among families raising disabled children
11. UNC study: Two-thirds of severe sports injuries to female students due to cheerleading

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...e to achieve exceptionally smooth surface finishin...such as ceramics, carbide and hardened tool steel ...-Hone® honing tool from Brush Research Techn...EB) November 10, 2009 -- Using exclusive, self-sha...lexible filaments, the Diamond Flex-Hone is a pate...
(Date:11/9/2009)... sizes looking to fast-track preparedness and resp...urce at their disposal. , ...source (HR) professionals looking to fast-track pr...mic have a new resource at their disposal. The Uni... Disease Research and Policy (CIDRAP), in collabor...
(Date:11/9/2009)...re-Asia-FirstCall/ -- Mindray Medical,Internationa...acturer and,marketer of medical devices worldwide,...results for the third quarter and nine months ende...tions as of September 30, 2009, -- Third quarte...se of, 3.1% over the third quarter of 2008. ...
(Date:11/9/2009)... promise to not expand abortion ,, Senate mus...rned for poor, elderly ,, WASHINGTON, Nov. 9 /...of Chicago, president of the United States Confere...ision of the U.S. House of Representatives to bloc... elective abortions. ,, In a statement issued ...
(Date:11/9/2009)...Variance Across the World is Critical in Understan... (Vocus) November 9, 2009 -- Understanding patie...ble when analyzing and interpreting scientific res...ned the genomes of 4,000 people throughout Europe ...an and Michael F. Seldin of the University of Cali...
Breaking Medicine News(10 mins):Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2
..., OH January 14, 2009 Obesity continues to incre...mong African-American and Mexican-American women. ... 3.3 million white women, 1.4 million African-Amer...creased risk for midlife obesity among Mexican-Ame...
...cing the First and Only Non-Drowsy Allergy Medicin....J., Jan. 14 Schering-Plough Corporation (NYSE: ...RITIN(R) Liqui-Gels(R), the first and only non-dro...lief for the worst allergy symptoms without causin...
...E, N.J., Jan. 14 Nephros, Inc. (Amex: NEP ), is...tigious 2009 Frost & Sullivan Medical Device P...apid growth, progressive technology, and strategic...tion technology has resulted in rapid revenue grow...
...RSE CITY, Mich., Jan. 14 Versus Technology,Inc. (... Management(TM) at,Anne Arundel Medical Center (AA...of efficiency and equipment monitoring at the 300+...al center, improving staff,efficiency and allowing...
...eople sickened in outbreak rises to 425 in 43 stat...hDay News) -- As the number of people sickened by ...in 43 states, state health officials said Tuesday ...ometowns haven,t been released, died from salmonel...
... Promotes the Pearl of Wisdom(TM) as Worldwide Sym..., Jan. 14 Marking Cervical Cancer Awareness Month... health advocacy groups, policymakers, healthcare ...Pearl of Wisdom Campaign to Prevent Cervical Cance...
Other Medicine News:Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 3Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 2Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 3Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 4Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 5Health News:Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award 6Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 2Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 3Health News:Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center 4Health News:Salmonella Linked to Deaths in Virginia, Minnesota 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 3Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 2Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 3Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 4
(Date:11/9/2009)...Nov. 9 Hologic, Inc. (Ho...developer, manufacturer and supplier of premium di...oducts dedicated to serving the healthcare needs o...h quarter and fiscal year ended September 26, 2009...f Directors has promoted Robert Cascella to Chief ...
(Date:11/9/2009)...lands, Nov. 9 Momentum is buildin...third CPhI India and second P-MEC India pharma ing...ned total of over 600 exhibitors from over 80 ...Centre for the 2009 events, being held on 1 - 3 De...ors, the 2009 events include two new launches. Bi...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Glenmarks Novel Molecule for Diabetes Melogliptin to Enter Phase III Trials 12766 1Glenmarks Novel Molecule for Diabetes Melogliptin to Enter Phase III Trials 12766 2Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 1Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 2
...tion at EASL on April 13, 2007, 2007, SAN DIEGO, a...all/ -- Anadys Pharmaceuticals, Inc. and LG Life,S...dy showing that,ANA380 (LB80380) retains potency a...s (HBV) which are resistant to lamivudine,adefovi...ntation at,the 42nd Annual Meeting of the European...
...ucleoside-Naive Chronic Hepatitis B e-Antigen,(HBe...Load by Week,48 of Re-Treatment, PRINCETON, N.J., ...yers Squibb Company today announced data from a co...patitis B patients,(ETV-027/901, n=99). These data...vels of hepatitis B virus in the blood,after inter...
Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5
... doors, 8 shelves. Over-sized compressor. Tripl...scent interior lighting. Self-Contained System No... Full One Year Warranty on Parts & Labor and an Ad...ilable as a chromatography unit which includes two...
... door 4 shelves. Over-sized compressor. Triple ...ent interior lighting. Self-Contained System No p...ull One Year Warranty on Parts & Labor and an Addi...able as a chromatography unit which includes two a...
Flammable Chemical Storage Cabinets, Justrite Model J25452
Flammable Chemical Storage Cabinets
Medicine Products: